References
- Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–1131.
- Creanga AA, Berg CJ, Syverson C, et al. Pregnancy-related mortality in the United States, 2006–2010. Obstet Gynecol. 2015;125:5–12.
- Cantwell R, Clutton Brock T, Cooper G, et al. Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118:1–203.
- Valensise H, Vasapollo B, Gadgliardi G, et al. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52:873–880.
- Von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22:143–148.
- Aksornphusitaphong A, Phupong V. Risk factors of early and late onset pre-eclampsia. J Obstet Gynaecol Res. 2013;39:627–631.
- Stergiotou I, Crispi F, Valenzuela Alcaraz B, et al. Patterns of maternal vascular remodeling and responsiveness in early- versus late-onset preeclampsia. Am J Obstet Gynecol. 2013;209:1–14.
- Pringle KG, Kind KL, Sferruzzi Perri AN, et al. Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy. Hum Reprod Update. 2010;16:415–431.
- Caniggia I, Mostachfi H, Winter J, et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGF beta (3). J Clin Invest. 2000;105:577–587.
- Patel J, Landers K, Mortimer RH, et al. Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development. Placenta. 2010;31:951–957.
- Iriyama T, Wang W, Parchim NF, et al. Hypoxia-ındependent upregulation of placental hypoxia ınducible factor-1α gene expression contributes to the pathogenesis of preeclampsia. Hypertension. 2015;6:1307–1315.
- Stubert J, Richter DU, Gerber B, et al. Expression pattern of progranulin in the human placenta and its effect on cell proliferation in the choriocarcinoma cell line BeWo. J Reprod Dev. 2011;57:229–235.
- Stubert J, Schattenberg F, Richter DU, et al. Trophoblastic progranulin expression is upregulated in cases of fetal growth restriction and preeclampsia. J Perinat Med. 2012;40:475–481.
- Stubert J, Kleber T, Bolz M, et al. Acute-phase proteins in prediction of preeclampsia in patients with abnormal midtrimester uterine Doppler velocimetry. Arch Gynecol Obstet. 2016;294:1151–1160.
- Acıkgoz SA, Tuten A, Oncul M, et al. Evaluation of maternal serum progranulin levels in normotensive pregnancies, and pregnancies with early- and late-onset preeclampsia. J Matern Fetal Neonatal Med. 2016;29:2658–2664.
- Couchman JR. Syndecans: proteoglycan regulators of cell-surface microdomains? Nat Rev Mol Cell Biol. 2003;4:926–937.
- Yoneda A, Couchman JR. Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. Matrix Biol. 2003;22:25–33.
- Jokimaa VI, Kujari HP, Ekholm EM, et al. Placental expression of syndecan 1 is diminished in preeclampsia. Am J Obstet Gynecol. 2000;183:1495–1498.
- Ogawa M, Yanoma S, Nagashima Y, et al. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key. Placenta. 2007;28:224–232.
- Heyer Chauhan N, Ovbude J, Hills AA, et al. Placental syndecan-1 and sulphated glycosaminoglycans are decreased in preeclampsia. J Perinat Med. 2014;42:329–338.
- Hadlock FP, Harrist RB, Sharman RS, et al. Estimation of fetal weight with the use of head, body, and femur measurements, a prospective study. Am J Obstet Gynecol. 1985;151:333–337.
- Kurmanavicius J, Florio I, Wisser J, et al. Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24–42 weeks of gestation. Ultrasound Obstet Gynecol. 1997;10:112–120.
- Redman CW, Sargent IL. Placental stress and preeclampsia: a revised view. Placenta. 2009;30:38–S42.
- Genbacev O, Zhou Y, Ludlow JW, et al. Regulation of human placental development by oxygen tension. Science. 1997;277:1669–1672.
- Greer SN, Metcalf JL, Wang Y, et al. The updated biology of hypoxia-inducible factor. Embo J. 2012;31:2448–2460.
- Kuschel A, Simon P, Tug S. Functional regulation of HIF-1α under normoxia is there more than post-translational regulation?. J Cell Physiol. 2012;227:514–524.
- Sumbayev VV, Nicholas SA. Hypoxia-inducible factor 1 as one of the “signaling drivers” of Toll-like receptor-dependent and allergic inflammation. Arch Immunol Ther Exp. 2010;58:287–294.
- Akhiles M, Mahalingam V, Nalliah S, et al. Hypoxia-inducible factor-1α as a predictive marker in pre-eclampsia. Biomed Rep. 2013;1:257–258.
- Bobek G, Surmon L, Mirabito KM, et al. Placental regulation of ınflammation and hypoxia after TNF-α ınfusion in mice. Am J Reprod Immunol. 2015;74:407–418.
- Sitras V, Paulssen RH, Gronaas H, et al. Differential placental gene expression in severe preeclampsia. Placenta. 2009;30:424–433.
- Cerdeira AS, Karumanchi SA. Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb Perspect Med. 2012;2:1–18.
- Gandley RE, Althouse A, Jeyabalan A, et al. Low soluble syndecan-1 precedes preeclampsia. PLoS One. 2016;6:1–18.